CoChat
Sign Up
Cited by 253

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation

Versey, Zoya, da Cruz Nizer, Waleska Stephanie, Russell, Emily, Zigic, Sandra, DeZeeuw, Katrina G., Marek, Jonah E., Overhage, Joerg, Cassol, Edana·2021·Frontiers in Immunology
DOI 10.3389/fimmu.2021.648554PMC PMC8062706
Open this paper in CoChat — free account

Abstract

Delayed wound healing can cause significant issues for immobile and ageing individuals as well as those living with co-morbid conditions such as diabetes, cardiovascular disease, and cancer. These delays increase a patient’s risk for infection and, in severe cases, can result in the formation of chronic, non-healing ulcers (e.g., diabetic foot ulcers, surgical site infections, pressure ulcers and venous leg ulcers). Chronic wounds are very difficult and expensive to treat and there is an urgent need to develop more effective therapeutics that restore healing processes. Sustained innate immune activation and inflammation are common features observed across most chronic wound types. However, the factors driving this activation remain incompletely understood. Emerging evidence suggests that the composition and structure of the wound microbiome may play a central role in driving this dysregulated activation but the cellular and molecular mechanisms underlying these processes require further investigation. In this review, we will discuss the current literature on: 1) how bacterial populations and biofilms contribute to chronic wound formation, 2) the role of bacteria and biofilms in driving dysfunctional innate immune responses in chronic wounds, and 3) therapeutics currently available (or underdevelopment) that target bacteria-innate immune interactions to improve healing. We will also discuss potential issues in studying the complexity of immune-biofilm interactions in chronic wounds and explore future areas of investigation for the field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2021.648554

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of skin microbiota according to the physiological sites: dry (green): buttock, volar forearm, hypothenar palm; moist (yellow): plantar heel, popliteal fossa, toe web space, axillary vault, and nare; sebaceous (purple): back, occiput, retroauricular crease, and glabella. Developed using data from (27).
Figure 1 Schematic of skin microbiota according to the physiological sites: dry (green): buttock, volar forearm, hypothenar palm; moist (yellow): plantar heel, popliteal fossa, toe web space, axillary vault, and nare; sebaceous (purple): back, occiput, retroauricular crease, and glabella. Developed using data from (27).CC BY · PubMed Central
Figure 2 Contribution of innate immune cells and inflammation to timely and delayed wound healing. (A) Representation of the four phases of wound healing ([1] Hemostasis, [2] Inflammation, [3] Proliferation and [4] Tissue Remodeling). (B) Chronic wounds are stalled in the inflammatory stage. We hypothesize that this inflammation is sustained by chronic activation of the innate immune system, which is driven their interactions and responses to polymicrobial biofilms found in and on the wound bed. DAMPs, damage-associate molecular patterns; PAMPs, pathogen-associated molecular patterns; MMPs, matrix metalloproteinases; ROS, reactive oxygen species; AMPs, antimicrobial peptides; TIMPs, tissue inhibitor of metalloproteinases. Created with BioRender.com.
Figure 2 Contribution of innate immune cells and inflammation to timely and delayed wound healing. (A) Representation of the four phases of wound healing ([1] Hemostasis, [2] Inflammation, [3] Proliferation and [4] Tissue Remodeling). (B) Chronic wounds are stalled in the inflammatory stage. We hypothesize that this inflammation is sustained by chronic activation of the innate immune system, which is driven their interactions and responses to polymicrobial biofilms found in and on the wound bed. DAMPs, damage-associate molecular patterns; PAMPs, pathogen-associated molecular patterns; MMPs, matrix metalloproteinases; ROS, reactive oxygen species; AMPs, antimicrobial peptides; TIMPs, tissue inhibitor of metalloproteinases. Created with BioRender.com.CC BY · PubMed Central
Figure 3 Targeting bacteria-innate immune interactions to restore healing in chronic wounds. Standard therapies such as debridement, NPWT, antiseptics, and antibiotics have been shown to reduce bacterial bioburden in the wound bed, but they do not always restore healing processes. New therapeutics that have both antimicrobial and immunomodulatory properties may be able to overcome the limitations of more traditional treatments. Here, we show novel therapeutics that target these interactions that can be used in early and late stages of healing to restore tissue homeostasis. LPS, lipopolysaccharide; EPS, extracellular polymeric substance; PGA, peptidoglycan; AMP, antimicrobial peptide; mAb, monoclonal antibody; miRNA, microRNA. Created with BioRender.com.
Figure 3 Targeting bacteria-innate immune interactions to restore healing in chronic wounds. Standard therapies such as debridement, NPWT, antiseptics, and antibiotics have been shown to reduce bacterial bioburden in the wound bed, but they do not always restore healing processes. New therapeutics that have both antimicrobial and immunomodulatory properties may be able to overcome the limitations of more traditional treatments. Here, we show novel therapeutics that target these interactions that can be used in early and late stages of healing to restore tissue homeostasis. LPS, lipopolysaccharide; EPS, extracellular polymeric substance; PGA, peptidoglycan; AMP, antimicrobial peptide; mAb, monoclonal antibody; miRNA, microRNA. Created with BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 225

  1. Morton, 2016, Wound healing and treating wounds, J Am Acad Dermatol, 74, 589, 10.1016/j.jaad.2015.08.068 · DOI · Paper page
  2. Järbrink, 2017, The humanistic and economic burden of chronic wounds: a protocol for a systematic review, Systematic Rev, 6, 15, 10.1186/s13643-016-0400-8 · DOI
  3. Tricco, 2015, A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types, BMC Med, 13, 90, 10.1186/s12916-015-0326-3 · DOI
  4. Percival, 2010, Biofilms and bacterial imbalances in chronic wounds: anti-Koch, Int Wound J, 7, 10.1111/j.1742-481X.2010.00668.x · DOI
  5. Wolcott, 2016, Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing, Wound Repair Regeneration, 24, 10.1111/wrr.12370 · DOI
  6. Metcalf, 2013, Biofilm delays wound healing: A review of the evidence, Burns Trauma, 1, 5, 10.4103/2321-3868.113329 · DOI
  7. Lopez, 2010, Biofilms, Cold Spring Harbor Perspect Biol, 2, a000398, 10.1101/cshperspect.a000398 · DOI
  8. Malone, 2017, The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data, J Wound Care, 26, 10.12968/jowc.2017.26.1.20 · DOI
  9. Kirketerp-Møller, 2020, The zone model: A conceptual model for understanding the microenvironment of chronic wound infection, Wound Repair Regeneration, 28, 10.1111/wrr.12841 · DOI
  10. Frieri, 2017, Antibiotic resistance, J Infect Public Health, 10, 10.1016/j.jiph.2016.08.007 · DOI
  11. Bjarnsholt, 2013, Applying insights from biofilm biology to drug development — can a new approach be developed, Nat Rev Drug Discovery, 12, 791, 10.1038/nrd4000 · DOI
  12. Høiby, 2015, ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
  13. Hall, 2017, Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria, FEMS Microbiol Rev, 41, 276, 10.1093/femsre/fux010 · DOI
  14. Høiby, 2010, Antibiotic resistance of bacterial biofilms, Int J Antimicrobial Agents, 35, 10.1016/j.ijantimicag.2009.12.011 · DOI
  15. Percival, 2012, A review of the scientific evidence for biofilms in wounds, Wound Repair Regeneration, 20, 10.1111/j.1524-475X.2012.00836.x · DOI
  16. Flemming, 2016, Biofilms: an emergent form of bacterial life, Nat Rev Microbiol, 14, 10.1038/nrmicro.2016.94 · DOI · Paper page
  17. Wu, 2019, Biofilms in Chronic Wounds: Pathogenesis and Diagnosis, Trends Biotechnol, 37, 10.1016/j.tibtech.2018.10.011 · DOI
  18. Lebeaux, 2013, From in vitro to in vivo Models of Bacterial Biofilm-Related Infections, Pathogens, 2, 288, 10.3390/pathogens2020288 · DOI
  19. Martin, 2010, Molecular Microbiology: New Dimensions for Cutaneous Biology and Wound Healing, J Invest Dermatol, 130, 38, 10.1038/jid.2009.221 · DOI
  20. Ursell, 2012, Defining the human microbiome, Nutr Rev, 70, 10.1111/j.1753-4887.2012.00493.x · DOI · Paper page
  21. Ursell, 2014, The Intestinal Metabolome: An Intersection Between Microbiota and Host, Gastroenterology, 146, 10.1053/j.gastro.2014.03.001 · DOI
  22. Wang, 2017, The Human Microbiota in Health and Disease, Engineering, 3, 71, 10.1016/J.ENG.2017.01.008 · DOI
  23. Sender, 2016, Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans, Cell, 164, 10.1016/j.cell.2016.01.013 · DOI · Paper page
  24. Hasan, 2019, Factors affecting the composition of the gut microbiota, and its modulation, PeerJ, 7, e7502, 10.7717/peerj.7502 · DOI
  25. Grice, 2011, The skin microbiome, Nat Rev Microbiol, 9, 10.1038/nrmicro2537 · DOI · Paper page
  26. Grice, 2009, Topographical and Temporal Diversity of the Human Skin Microbiome, Science, 324, 10.1126/science.1171700 · DOI · Paper page
  27. Daeschlein, 2013, Antimicrobial and antiseptic strategies in wound management, Int Wound J, 10, 9, 10.1111/iwj.12175 · DOI
  28. Bowler, 2001, Wound Microbiology and Associated Approaches to Wound Management, Clin Microbiol Rev, 14, 10.1128/CMR.14.2.244-269.2001 · DOI · Paper page
  29. Orsted, 2017, Best practice recommendations for the prevention and management of wounds, 74
  30. Negut, 2018, Treatment Strategies for Infected Wounds, Molecules, 23, 10.3390/molecules23092392 · DOI
  31. Kingsley, 2003, The wound infection continuum and its application to clinical practice, Ostomy Manage, 49, 1
  32. Gardner, 2008, Wound bioburden and infection-related complications in diabetic foot ulcers, Biol Res Nurs, 10, 44, 10.1177/1099800408319056 · DOI
  33. Baviera, 2014, Microbiota in healthy skin and in atopic eczema, BioMed Res Int, 2014, 10.1155/2014/436921 · DOI
  34. Grice, 2008, A diversity profile of the human skin microbiota, Genome Res, 18, 10.1101/gr.075549.107 · DOI
  35. Tuttle, 2015, Association Between Microbial Bioburden and Healing Outcomes in Venous Leg Ulcers: A Review of the Evidence, Adv Wound Care, 4, 1, 10.1089/wound.2014.0535 · DOI
  36. Smith, 2016, One step closer to understanding the role of bacteria in diabetic foot ulcers: characterising the microbiome of ulcers, BMC Microbiol, 16, 54, 10.1186/s12866-016-0665-z · DOI
  37. Wolcott, 2016, Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing, Wound Repair Regeneration, 24, 10.1111/wrr.12370 · DOI
  38. Malone, 2017, Next Generation DNA Sequencing of Tissues from Infected Diabetic Foot Ulcers, EBioMedicine, 21, 10.1016/j.ebiom.2017.06.026 · DOI
  39. Kalan, 2019, Strain- and Species-Level Variation in the Microbiome of Diabetic Wounds Is Associated with Clinical Outcomes and Therapeutic Efficacy, Cell Host Microbe, 25, 10.1016/j.chom.2019.03.006 · DOI
  40. Kpeli, 2019, “Secondary infection of Buruli ulcer lesions,”, 10.1007/978-3-030-11114-4_13 · DOI
  41. Meisel, 2016, Skin Microbiome Surveys Are Strongly Influenced by Experimental Design, J Invest Dermatol, 136, 10.1016/j.jid.2016.01.016 · DOI
  42. Kong, 2017, Performing Skin Microbiome Research: A Method to the Madness, J Invest Dermatol, 137, 10.1016/j.jid.2016.10.033 · DOI
  43. Travis, 2020, The microbiome of diabetic foot ulcers: a comparison of swab and tissue biopsy wound sampling techniques using 16S rRNA gene sequencing, BMC Microbiol, 20, 163, 10.1186/s12866-020-01843-2 · DOI
  44. Wolcott, 2008, A rapid molecular method for characterising bacterial bioburden in chronic wounds, J Wound Care, 17, 10.12968/jowc.2008.17.12.31769 · DOI
  45. Jneid, 2017, The diabetic foot microbiota: A review, Hum Microbiome J, 1, 10.1016/j.humic.2017.09.002 · DOI
  46. Tomic-Canic, 2020, Skin Microbiota and its Interplay with Wound Healing, Am J Clin Dermatol, 21, 36, 10.1007/s40257-020-00536-w · DOI
  47. Jahns, 2012, An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study, Br J Dermatol, 167, 10.1111/j.1365-2133.2012.10897.x · DOI
  48. Lazarus, 1994, Definitions and Guidelines for Assessment of Wounds and Evaluation of Healing, Arch Dermatol, 130, 489, 10.1001/archderm.1994.01690040093015 · DOI
  49. Pereira, 2017, Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies, Front Microbiol, 8, 10.3389/fmicb.2017.01791 · DOI
  50. Rahim, 2017, Bacterial Contribution in Chronicity of Wounds, Microbial Ecol, 73, 10.1007/s00248-016-0867-9 · DOI
  51. Percival, 2018, Role of anaerobes in polymicrobial communities and biofilms complicating diabetic foot ulcers, Int Wound J, 15, 10.1111/iwj.12926 · DOI
  52. Sadeghpour Heravi, 2019, Bacterial Diversity of Diabetic Foot Ulcers: Current Status and Future Prospectives, J Clin Med, 8, 10.3390/jcm8111935 · DOI
  53. Dowd, 2008, Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing, BMC Microbiol, 8, 10.1186/1471-2180-8-43 · DOI
  54. Noor, 2016, Culture-Based Screening of Aerobic Microbiome in Diabetic Foot Subjects and Developing Non-healing Ulcers, Front Microbiol, 7, 10.3389/fmicb.2016.01792 · DOI
  55. Jneid, 2018, Exploring the Microbiota of Diabetic Foot Infections With Culturomics, Front Cell Infect Microbiol, 8, 10.3389/fcimb.2018.00282 · DOI
  56. Suryaletha, 2018, Metataxonomic approach to decipher the polymicrobial burden in diabetic foot ulcer and its biofilm mode of infection, Int Wound J, 15, 10.1111/iwj.12888 · DOI
  57. Johani, 2019, Understanding the microbiome of diabetic foot osteomyelitis: insights from molecular and microscopic approaches, Clin Microbiol Infect, 25, 10.1016/j.cmi.2018.04.036 · DOI
  58. Jnana, 2020, Microbial Community Distribution and Core Microbiome in Successive Wound Grades of Individuals with Diabetic Foot Ulcers, Appl Environ Microbiol, 86, 10.1128/AEM.02608-19 · DOI
  59. Min, 2020, Association between baseline abundance of Peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs, PloS One, 15, e0227006, 10.1371/journal.pone.0227006 · DOI
  60. Sweere, 2020, The Immune Response to Chronic Pseudomonas aeruginosa Wound Infection in Immunocompetent Mice, Adv Wound Care, 9, 35, 10.1089/wound.2019.1039 · DOI
  61. Klein, 2018, A porcine model of skin wound infected with a polybacterial biofilm, Biofouling, 34, 10.1080/08927014.2018.1425684 · DOI
  62. Trøstrup, 2017, Chronic Pseudomonas aeruginosa Biofilm Infection Impairs Murine S100A8/A9 and Neutrophil Effector Cytokines – Implications for Delayed Wound Closure, Pathog Dis, 75, ftx068, 10.1093/femspd/ftx068 · DOI
  63. Trøstrup, 2018, Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor, Int Wound J, 15, 10.1111/iwj.12846 · DOI
  64. Canesso, 2014, Skin Wound Healing Is Accelerated and Scarless in the Absence of Commensal Microbiota, J Immunol, 193, 10.4049/jimmunol.1400625 · DOI
  65. Seth, 2012, Comparative Analysis of Single-Species and Polybacterial Wound Biofilms Using a Quantitative, In Vivo, Rabbit Ear Model, PloS One, 7, e42897, 10.1371/journal.pone.0042897 · DOI
  66. Gurjala, 2011, Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing, Wound Repair Regeneration, 19, 10.1111/j.1524-475X.2011.00690.x · DOI
  67. Kim, 2008, Dynamics of Neutrophil Infiltration during Cutaneous Wound Healing and Infection Using Fluorescence Imaging, J Invest Dermatol, 128, 10.1038/sj.jid.5701223 · DOI
  68. van der Laan, 2001, Immunohistopathological appearance of three different types of injury in human skin, Inflammation Res, 50, 10.1007/PL00000255 · DOI
  69. Thomsen, 2010, The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods, Wound Repair Regeneration, 18, 38, 10.1111/j.1524-475X.2009.00561.x · DOI
  70. Horton, 2015, The Cutaneous Microbiome in Outpatients Presenting With Acute Skin Abscesses, J Infect Dis, 211, 10.1093/infdis/jiv003 · DOI
  71. Prieto-Borja, 2016, Sonication of Abdominal Drains: Clinical Implications of Quantitative Cultures for the Diagnosis of Surgical Site Infection, Surg Infect, 17, 10.1089/sur.2015.268 · DOI
  72. Cuchí, 2020, Relationship between skin and urine colonization and surgical site infection in the proximal femur fracture: a prospective study, Int Orthopaedics, 44, 10.1007/s00264-020-04525-w · DOI
  73. de Wert, 2020, The cutaneous microbiome in hospitalized patients with pressure ulcers, Sci Rep, 10, 5963, 10.1038/s41598-020-62918-8 · DOI
  74. Johnson, 2016, Bacterial Etiology and Risk Factors Associated with Cellulitis and Purulent Skin Abscesses in Military Trainees, PloS One, 11, e0165491, 10.1371/journal.pone.0165491 · DOI
  75. Vierhout, 2019, Inguinal microbiome in patients undergoing an endovascular aneurysm repair: Application of next-generation sequencing of the 16S-23S rRNA regions, Med Hypotheses, 132, 10.1016/j.mehy.2019.109358 · DOI
  76. Eming, 2014, Wound repair and regeneration: Mechanisms, signaling, and translation, Sci Trans Med, 6, 10.1126/scitranslmed.3009337 · DOI · Paper page
  77. Larouche, 2018, Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets, Adv Wound Care, 7, 10.1089/wound.2017.0761 · DOI
  78. Cañedo-Dorantes, 2019, Skin Acute Wound Healing: A Comprehensive Review, Int J Inflammation, 2019, 1, 10.1155/2019/3706315 · DOI
  79. Nguyen, 2019, The Dynamics of the Skin’s Immune System, Int J Mol Sci, 20, 10.3390/ijms20081811 · DOI
  80. Rodrigues, 2019, Wound Healing: A Cellular Perspective, Physiol Rev, 99, 665, 10.1152/physrev.00067.2017 · DOI
  81. Martins-Green, 2013, Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing, Adv Wound Care, 2, 10.1089/wound.2012.0380 · DOI
  82. de Oliveira, 2016, Neutrophil migration in infection and wound repair: going forward in reverse, Nat Rev Immunol, 16, 10.1038/nri.2016.49 · DOI · Paper page
  83. Theilgaard-Mönch, 2004, The Transcriptional Activation Program of Human Neutrophils in Skin Lesions Supports Their Important Role in Wound Healing, J Immunol, 172, 10.4049/jimmunol.172.12.7684 · DOI
  84. Kruger, 2015, Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury, PloS Pathog, 11, e1004651, 10.1371/journal.ppat.1004651 · DOI
  85. Krzyszczyk, 2018, The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes, Front Physiol, 9, 10.3389/fphys.2018.00419 · DOI
  86. Rodero, 2014, In Vivo Imaging Reveals a Pioneer Wave of Monocyte Recruitment into Mouse Skin Wounds, PloS One, 9, e108212, 10.1371/journal.pone.0108212 · DOI
  87. Ishida, 2008, Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function, J Immunol, 180, 10.4049/jimmunol.180.1.569 · DOI · Paper page
  88. Ferrante, 2012, Regulation of Macrophage Polarization and Wound Healing, Adv Wound Care, 1, 10.1089/wound.2011.0307 · DOI
  89. Sorokin, 2010, The impact of the extracellular matrix on inflammation, Nat Rev Immunol, 10, 10.1038/nri2852 · DOI
  90. Daley, 2010, The phenotype of murine wound macrophages, J Leukocyte Biol, 87, 59, 10.1189/jlb.0409236 · DOI · Paper page
  91. Elliott, 2017, Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses, J Immunol, 198, 10.4049/jimmunol.1601520 · DOI · Paper page
  92. Zhao, 2016, Inflammation in Chronic Wounds, Int J Mol Sci, 17, 10.3390/ijms17122085 · DOI
  93. Sindrilaru, 2013, Disclosure of the Culprits: Macrophages—Versatile Regulators of Wound Healing, Adv Wound Care, 2, 10.1089/wound.2012.0407 · DOI · Paper page
  94. Wysocki, 1993, Wound Fluid from Chronic Leg Ulcers Contains Elevated Levels of Metalloproteinases MMP-2 and MMP-9, J Invest Dermatol, 101, 10.1111/1523-1747.ep12359590 · DOI · Paper page
  95. Bullen, 1995, Tissue Inhibitor of Metalloproteinases-1 Is Decreased and Activated Gelatinases Are Increased in Chronic Wounds, J Invest Dermatol, 104, 10.1111/1523-1747.ep12612786 · DOI
  96. Lobmann, 2002, Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients, Diabetologia, 45, 10.1007/s00125-002-0868-8 · DOI
  97. Diegelmann, 2003, Excessive neutrophils characterize chronic pressure ulcers, Wound Repair Regeneration, 11, 10.1046/j.1524-475X.2003.11617.x · DOI
  98. Diegelmann, 2004, Wound healing: an overview of acute, fibrotic and delayed healing, Front Biosci: J Virtual Library, 9, 283, 10.2741/1184 · DOI · Paper page
  99. Herrick, 1997, Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation, Lab Invest, 77
  100. Schafer, 2008, Oxidative stress in normal and impaired wound repair, Pharmacol Res, 58, 10.1016/j.phrs.2008.06.004 · DOI · Paper page
  101. Sen, 2009, Wound healing essentials: Let there be oxygen, Wound Repair Regeneration, 17, 1, 10.1111/j.1524-475X.2008.00436.x · DOI
  102. Wong, 2015, Diabetes primes neutrophils to undergo NETosis, which impairs wound healing, Nat Med, 21, 10.1038/nm.3887 · DOI · Paper page
  103. Dunnill, 2017, Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process, Int Wound J, 14, 89, 10.1111/iwj.12557 · DOI
  104. Klinkert, 2017, Selective M2 Macrophage Depletion Leads to Prolonged Inflammation in Surgical Wounds, Eur Surg Res, 58, 10.1159/000451078 · DOI
  105. Trøstrup, 2016, S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus, Arch Dermatol Res, 308, 10.1007/s00403-016-1646-7 · DOI
  106. Zhao, 2010, Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds, Wound Repair Regeneration, 18, 10.1111/j.1524-475X.2010.00608.x · DOI · Paper page
  107. Zhao, 2012, Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model, Wound Repair Regeneration, 20, 10.1111/j.1524-475X.2012.00793.x · DOI · Paper page
  108. Watters, 2013, Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice, Med Microbiol Immunol, 202, 10.1007/s00430-012-0277-7 · DOI
  109. Brandenburg, 2018, Novel murine model for delayed wound healing using a biological wound dressing with Pseudomonas aeruginosa biofilms, Microbial Pathogen, 122, 10.1016/j.micpath.2018.05.043 · DOI
  110. Kim, 2019, High Levels of Oxidative Stress and Skin Microbiome are Critical for Initiation and Development of Chronic Wounds in Diabetic Mice, Sci Rep, 9, 19318, 10.1038/s41598-019-55644-3 · DOI
  111. Bjarnsholt, 2008, Why chronic wounds will not heal: a novel hypothesis, Wound Repair Regeneration, 16, 2, 10.1111/j.1524-475X.2007.00283.x · DOI
  112. Trøstrup, 2020, Insights into Host–Pathogen Interactions in Biofilm-Infected Wounds Reveal Possibilities for New Treatment Strategies, Antibiotics, 9, 10.3390/antibiotics9070396 · DOI
  113. Kirker, 2017, In vitro studies evaluating the effects of biofilms on wound-healing cells: a review, APMIS, 125, 10.1111/apm.12678 · DOI
  114. Ramond, 2019, Pivotal Role of Mitochondria in Macrophage Response to Bacterial Pathogens, Front Immunol, 10, 10.3389/fimmu.2019.02461 · DOI
  115. Yamada, 2019, Biofilm-Leukocyte Cross-Talk: Impact on Immune Polarization and Immunometabolism, J Innate Immun, 11, 10.1159/000492680 · DOI
  116. Meisel, 2018, Commensal microbiota modulate gene expression in the skin, Microbiome, 6, 20, 10.1186/s40168-018-0404-9 · DOI · Paper page
  117. di Domizio, 2020, The commensal skin microbiota triggers type I IFN–dependent innate repair responses in injured skin, Nat Immunol, 21, 10.1038/s41590-020-0721-6 · DOI
  118. Brandt, 2018, Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice, PloS Pathog, 14, e1007244, 10.1371/journal.ppat.1007244 · DOI
  119. Brandt, 2018, Excessive localized leukotriene B4 levels dictate poor skin host defense in diabetic mice, JCI Insight, 3, e120220, 10.1172/jci.insight.120220 · DOI
  120. Na, 2018, Lack of Receptor for Advanced Glycation End Products Leads to Less Severe Staphylococcal Skin Infection but More Skin Abscesses and Prolonged Wound Healing, J Infect Dis, 218, 791, 10.1093/infdis/jiy007 · DOI
  121. Thurlow, 2018, Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections, Cell Host Microbe, 24, 10.1016/j.chom.2018.07.001 · DOI
  122. Tanaka, 2017, MiR-142 Is Required for Staphylococcus aureus Clearance at Skin Wound Sites via Small GTPase-Mediated Regulation of the Neutrophil Actin Cytoskeleton, J Invest Dermatol, 137, 10.1016/j.jid.2016.11.018 · DOI
  123. Feuerstein, 2015, MyD88 in Macrophages Is Critical for Abscess Resolution in Staphylococcal Skin Infection, J Immunol, 194, 10.4049/jimmunol.1402566 · DOI
  124. Li, 2014, Interleukin-33 Increases Antibacterial Defense by Activation of Inducible Nitric Oxide Synthase in Skin, PloS Pathog, 10, e1003918, 10.1371/journal.ppat.1003918 · DOI
  125. Cho, 2012, Neutrophil-derived IL-1β Is Sufficient for Abscess Formation in Immunity against Staphylococcus aureus in Mice, PloS Pathog, 8, e1003047, 10.1371/journal.ppat.1003047 · DOI
  126. Kamen, 2011, Pyk2 Is Required for Neutrophil Degranulation and Host Defense Responses to Bacterial Infection, J Immunol, 186, 10.4049/jimmunol.1002093 · DOI
  127. Mahoney, 2002, Bacterial Colonization and the Expression of Inducible Nitric Oxide Synthase in Murine Wounds, Am J Pathol, 161, 10.1016/S0002-9440(10)64492-6 · DOI · Paper page
  128. Chen, 2018, Pseudomonas aeruginosa infection alters the macrophage phenotype switching process during wound healing in diabetic mice, Cell Biol Int, 42, 10.1002/cbin.10955 · DOI
  129. Nguyen, 2013, Deficient cytokine expression and neutrophil oxidative burst contribute to impaired cutaneous wound healing in diabetic, biofilm-containing chronic wounds, Wound Repair Regeneration, 21, 10.1111/wrr.12109 · DOI
  130. McInnes, 2014, Contrasting host immuno-inflammatory responses to bacterial challenge within venous and diabetic ulcers, Wound Repair Regeneration, 22, 58, 10.1111/wrr.12133 · DOI
  131. Fazli, 2011, Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds, Wound Repair Regeneration, 19, 10.1111/j.1524-475X.2011.00681.x · DOI · Paper page
  132. Chan, 2017, Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus, Infect Immun, 85, 10.1128/IAI.00876-16 · DOI
  133. Chan, 2018, Protective immunity in recurrent Staphylococcus aureus infection reflects localized immune signatures and macrophage-conferred memory, Proc Natl Acad Sci, 115, 10.1073/pnas.1808353115 · DOI
  134. McCaig, 2006, Staphylococcus aureus –associated Skin and Soft Tissue Infections in Ambulatory Care, Emerg Infect Dis, 12, 10.3201/eid1211.060190 · DOI
  135. Sivamani, 2014, Eicosanoids and Keratinocytes in Wound Healing, Adv Wound Care, 3, 10.1089/wound.2014.0523 · DOI
  136. Lohwasser, 2006, The Receptor for Advanced Glycation End Products Is Highly Expressed in the Skin and Upregulated by Advanced Glycation End Products and Tumor Necrosis Factor-Alpha, J Invest Dermatol, 126, 10.1038/sj.jid.5700070 · DOI
  137. Ramasamy, 2012, The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes, Vasc Pharmacol, 57, 10.1016/j.vph.2012.06.004 · DOI
  138. Mori, 2018, Identification and functional analysis of inflammation-related miRNAs in skin wound repair, Development Growth Differentiation, 60, 10.1111/dgd.12542 · DOI
  139. Xu, 2016, NADPH Oxidases Are Essential for Macrophage Differentiation, J Biol Chem, 291, 10.1074/jbc.M116.731216 · DOI
  140. Guo, 2016, AGEs Induced Autophagy Impairs Cutaneous Wound Healing via Stimulating Macrophage Polarization to M1 in Diabetes, Sci Rep, 6, 10.1038/srep36416 · DOI
  141. Gould, 2015, Chronic Wound Repair and Healing in Older Adults: Current Status and Future Research, J Am Geriatrics Soc, 63, 10.1111/jgs.13332 · DOI
  142. Swift, 1999, Impaired wound repair and delayed angiogenesis in aged mice, Lab Investigation J Tech Methods Pathol, 79
  143. Gosain, 2004, Aging and Wound Healing, World J Surg, 28, 10.1007/s00268-003-7397-6 · DOI
  144. Gomez, 2005, The aging innate immune system, Curr Opin Immunol, 17, 10.1016/j.coi.2005.07.013 · DOI
  145. Franceschi, 2006, Inflamm-aging: An Evolutionary Perspective on Immunosenescence, Ann New Y Acad Sci, 908, 10.1111/j.1749-6632.2000.tb06651.x · DOI · Paper page
  146. Lu, 1999, Chronic exercise increases macrophage-mediated tumor cytolysis in young and old mice, Am J Physiol-Regulatory Integr Comp Physiol, 276, 10.1152/ajpregu.1999.276.2.R482 · DOI
  147. Fulop, 2004, Signal transduction and functional changes in neutrophils with aging, Aging Cell, 3, 10.1111/j.1474-9728.2004.00110.x · DOI
  148. Armstrong, 2017, Diabetic Foot Ulcers and Their Recurrence, New Engl J Med, 376, 10.1056/nejmra1615439 · DOI · Paper page
  149. Baltzis, 2014, Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights, Adv Ther, 31, 10.1007/s12325-014-0140-x · DOI
  150. Pradhan, 2009, Inflammation and neuropeptides: the connection in diabetic wound healing, Expert Rev Mol Med, 11, e2, 10.1017/S1462399409000945 · DOI
  151. Netea, 2019, Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host’s Response to Pathogens, Cell Host Microbe, 25, 13, 10.1016/j.chom.2018.12.006 · DOI
  152. Wolcott, 2010, Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window, J Wound Care, 19, 10.12968/jowc.2010.19.8.77709 · DOI
  153. Yang, 2017, Effect of Negative Pressure Wound Therapy With Instillation on Bioburden in Chronically Infected Wounds, Wounds: Compendium Clin Res Pract, 29
  154. Guoqi, 2018, Negative pressure wound therapy reduces the motility of Pseudomonas aeruginosa and enhances wound healing in a rabbit ear biofilm infection model, Antonie Van Leeuwenhoek, 111, 10.1007/s10482-018-1045-5 · DOI
  155. Li, 2019, Impact of negative-pressure wound therapy on bacterial behaviour and bioburden in a contaminated full-thickness wound, Int Wound J, 16, 10.1111/iwj.13197 · DOI
  156. Glass, 2014, Systematic review of molecular mechanism of action of negative-pressure wound therapy, Br J Surg, 101, 10.1002/bjs.9636 · DOI
  157. Borys, 2019, Negative pressure wound therapy use in diabetic foot syndrome—from mechanisms of action to clinical practice, Eur J Clin Invest, 49, e13067, 10.1111/eci.13067 · DOI
  158. Karam, 2018, al Saeed M. Effect of negative pressure wound therapy on molecular markers in diabetic foot ulcers, Gene, 667, 56, 10.1016/j.gene.2018.05.032 · DOI
  159. Wang, 2019, Negative pressure wound therapy promoted wound healing by suppressing inflammation via down-regulating MAPK-JNK signaling pathway in diabetic foot patients, Diabetes Res Clin Pract, 150, 10.1016/j.diabres.2019.02.024 · DOI
  160. Hübner, 2010, Review on the Efficacy, Safety and Clinical Applications of Polihexanide, a Modern Wound Antiseptic, Skin Pharmacol Physiol, 23, 17, 10.1159/000318264 · DOI
  161. Koburger, 2010, Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate, J Antimicrobial Chemother, 65, 10.1093/jac/dkq212 · DOI
  162. Sopata, 2016, Antiseptic with modern wound dressings in the treatment of venous leg ulcers: Clinical and microbiological aspects, J Wound Care, 25, 10.12968/jowc.2016.25.8.419 · DOI
  163. Bigliardi, 2017, Povidone iodine in wound healing: A review of current concepts and practices, Int J Surg, 44, 10.1016/j.ijsu.2017.06.073 · DOI
  164. Gold, 2020, Topical stabilized hypochlorous acid: The future gold standard for wound care and scar management in dermatologic and plastic surgery procedures, J Cosmetic Dermatol, 19, 10.1111/jocd.13280 · DOI
  165. Leaper, 2015, Approach to chronic wound infections, Br J Dermatol, 173, 10.1111/bjd.13677 · DOI
  166. Wilkinson, 2011, Silver and nanoparticles of silver in wound dressings: A review of efficacy and safety, J Wound Care, 20, 10.12968/jowc.2011.20.11.543 · DOI
  167. Rodriguez-Arguello, 2018, A Scoping Review of the Use of Silver-impregnated Dressings for the Treatment of Chronic Wounds, Ostomy Wound Manage, 64, 14, 10.25270/owm.2018.3.1431 · DOI
  168. Schwarzer, 2020, The efficacy of topical agents used in wounds for managing chronic biofilm infections: A systematic review, J Infect, 80, 10.1016/j.jinf.2019.12.017 · DOI
  169. Nikolić, 2019, The Antiseptic Octenidine Inhibits Langerhans Cell Activation and Modulates Cytokine Expression upon Superficial Wounding with Tape Stripping, J Immunol Res, 2019, 1, 10.1155/2019/5143635 · DOI
  170. Pavlík, 2019, Dual role of iodine, silver, chlorhexidine and octenidine as antimicrobial and antiprotease agents, PloS One, 14, e0211055, 10.1371/journal.pone.0211055 · DOI
  171. Tzaneva, 2016, Antibiotic treatment and resistance in chronic wounds of vascular origin, Med Pharm Rep, 89, 10.15386/cjmed-647 · DOI
  172. Hernandez, 2006, The use of systemic antibiotics in the treatment of chronic wounds, Dermatol Ther, 19, 10.1111/j.1529-8019.2006.00091.x · DOI
  173. Lipsky, 2009, Topical Antimicrobial Therapy for Treating Chronic Wounds, Clin Infect Dis, 49, 10.1086/644732 · DOI
  174. CowlingT JonesS Topical Antibiotics for Infected Wounds: A Review of the Clinical Effectiveness and Guidelines2017
  175. Boyko, 2018, Review of the Current Management of Pressure Ulcers, Adv Wound Care, 7, 57, 10.1089/wound.2016.0697 · DOI
  176. Ramirez-Acuña, 2019, Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments, Antibiotics, 8, 10.3390/antibiotics8040193 · DOI
  177. Lipsky, 2012, Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa, Clin Infect Dis, 10.1093/cid/cis346 · DOI
  178. Rao, 2011, Treating Osteomyelitis: Antibiotics and Surgery, Plast Reconstruct Surg, 127, 10.1097/PRS.0b013e3182001f0f · DOI
  179. Shettigar, 2018, Severity of drug resistance and co-existence of Enterococcus faecalis in diabetic foot ulcer infections, Folia Microbiol, 63, 10.1007/s12223-017-0547-2 · DOI
  180. Chiang, 2013, Extracellular DNA Shields against Aminoglycosides in Pseudomonas aeruginosa Biofilms, Antimicrobial Agents Chemother, 57, 10.1128/AAC.00001-13 · DOI
  181. Germoni, 2016, The effect of alginate lyase on the gentamicin resistance of Pseudomonas aeruginosa in mucoid biofilms, J Appl Microbiol, 121, 10.1111/jam.13153 · DOI
  182. Fjell, 2012, Designing antimicrobial peptides: form follows function, Nat Rev Drug Discovery, 11, 37, 10.1038/nrd3591 · DOI
  183. Luong, 2020, Antimicrobial peptides – Advances in development of therapeutic applications, Life Sci, 260, 10.1016/j.lfs.2020.118407 · DOI
  184. Mookherjee, 2020, Antimicrobial host defence peptides: functions and clinical potential, Nat Rev Drug Discovery, 19, 10.1038/s41573-019-0058-8 · DOI · Paper page
  185. Mangoni, 2016, Antimicrobial peptides and wound healing: biological and therapeutic considerations, Exp Dermatol, 25, 10.1111/exd.12929 · DOI
  186. Strempel, 2014, Potential Application of Antimicrobial Peptides in the Treatment of Bacterial Biofilm Infections, Curr Pharm Design, 21, 67, 10.2174/1381612820666140905124312 · DOI
  187. Eckert, 2004, S100 proteins in the epidermis, J Invest Dermatol, 123, 23, 10.1111/j.0022-202X.2004.22719.x · DOI
  188. Schröder, 2006, Antimicrobial skin peptides and proteins, Cell Mol Life Sci, 63, 10.1007/s00018-005-5364-0 · DOI
  189. Overhage, 2008, Human host defense peptide LL-37 prevents bacterial biofilm formation, Infect Immun, 76, 10.1128/IAI.00318-08 · DOI
  190. Semple, 2011, Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF, Eur J Immunol, 41, 10.1002/eji.201141648 · DOI
  191. Semple, 2010, Human β-defensin 3 has immunosuppressive activity in vitro and in vivo, Eur J Immunol, 40, 10.1002/eji.200940041 · DOI
  192. Jin, 2010, An Antimicrobial Peptide Regulates Tumor-Associated Macrophage Trafficking via the Chemokine Receptor CCR2, a Model for Tumorigenesis, PloS One, 5, e10993, 10.1371/journal.pone.0010993 · DOI
  193. Ramos, 2011, Wound healing activity of the human antimicrobial peptide LL37, Peptides, 32, 10.1016/j.peptides.2011.06.005 · DOI
  194. Duplantier, 2013, The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds, Front Immunol, 4, 10.3389/fimmu.2013.00143 · DOI
  195. Tokumaru, 2005, Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-37, J Immunol, 175, 10.4049/jimmunol.175.7.4662 · DOI
  196. Koczulla, 2003, An angiogenic role for the human peptide antibiotic LL-37/hCAP-18, J Clin Invest, 111, 10.1172/JCI17545 · DOI
  197. Felgueiras, 2020, Antimicrobial action and clotting time of thin, hydrated poly(vinyl alcohol)/cellulose acetate films functionalized with LL37 for prospective wound-healing applications, J Appl Polymer Sci, 137, 10.1002/app.48626 · DOI
  198. Fumakia, 2016, Nanoparticles Encapsulated with LL37 and Serpin A1 Promotes Wound Healing and Synergistically Enhances Antibacterial Activity, Mol Pharmaceut, 13, 10.1021/acs.molpharmaceut.6b00099 · DOI
  199. Bolatchiev, 2020, Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo, Fundam Clin Pharmacol, 34, 10.1111/fcp.12499 · DOI
  200. Garcia-Orue, 2016, LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds, Eur J Pharmaceut Biopharmaceut, 108, 10.1016/j.ejpb.2016.04.006 · DOI

200 of 225 shown

Cited by

Sorted by citations

Metadata

Authors
Versey, Z., da Cruz Nizer, W. S., Russell, E., Zigic, S., DeZeeuw, K. G., Marek, J. E., Overhage, J., & Cassol, E.
Venue
Frontiers in Immunology
Publisher
Frontiers Media SA
Published
2021-04-09
Volume
12
ISSN
1664-3224
DOI
10.3389/fimmu.2021.648554
PMC
PMC8062706
Cited by
253
References
35
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review